Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival-Reference-Cited by-同舟云学术

Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival

Published:2010-02 Issue:1-3 Volume:628 Page:132-139
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Kim Hyun Soo,Cho Jang Eun,Hwang Ki Chul,Shim Yeon Hee,Lee Jung Hwa,Kwak Young Lan

Publisher

Elsevier BV

Subject

Pharmacology

Reference50 articles.

1. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study;Abbud;Am. Heart J.,1995

2. Endogenous angiotensin-(1–7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats;Al-Maqhrebi;Pharmacol. Res.,2009

3. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure;Arai;Circ. Res.,1994

4. Importance of timing of magnesium administration in the isolated ischemic-reperfused rat heart: role of KATP channels;Bazargan;Physiol. Res.,2008

5. Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats;Choi;Am. J. Physiol. Heart Circ. Physiol.,2002

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the opioid remifentanil: Protective effects and molecular mechanisms against organ ischemia-reperfusion injury;Biomedicine & Pharmacotherapy;2023-11

2. THE STRESS HYPERGLYCEMIA RATIO ISA MARKER FOR AN INCREASED RISK OF MYOCARDIAL ISCHEMIA-REPERFUSION INJURY AFTER MYOCARDIAL INFARCTION;ACTA MEDICA MEDITERR;2023

3. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning;Pharmacological Reviews;2022-12-08

4. Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning;Vascular Pharmacology;2022-06

5. WITHDRAWN: DUSP6 alleviates myocardial ischemia-reperfusion injury via repressing ERK1/2 signaling;Biochemical and Biophysical Research Communications;2021-11